U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.33G>T (p.Gln11His) AND Hereditary cancer-predisposing syndrome

Germline classification:
Benign/Likely benign (3 submissions)
Last evaluated:
Jan 11, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000115633.16

Allele description [Variation Report for NM_000465.4(BARD1):c.33G>T (p.Gln11His)]

NM_000465.4(BARD1):c.33G>T (p.Gln11His)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.33G>T (p.Gln11His)
Other names:
p.Q11H:CAG>CAT
HGVS:
  • NC_000002.12:g.214809537C>A
  • NG_012047.3:g.5175G>T
  • NM_000465.4:c.33G>TMANE SELECT
  • NM_001282543.2:c.33G>T
  • NM_001282545.2:c.33G>T
  • NM_001282548.2:c.33G>T
  • NM_001282549.2:c.33G>T
  • NP_000456.2:p.Gln11His
  • NP_001269472.1:p.Gln11His
  • NP_001269474.1:p.Gln11His
  • NP_001269477.1:p.Gln11His
  • NP_001269478.1:p.Gln11His
  • LRG_297t1:c.33G>T
  • LRG_297:g.5175G>T
  • LRG_297p1:p.Gln11His
  • NC_000002.11:g.215674261C>A
  • NG_012047.2:g.5168G>T
  • NM_000465.2:c.33G>T
  • NM_000465.3:c.33G>T
  • NR_104212.2:n.147G>T
  • NR_104215.2:n.147G>T
  • NR_104216.2:n.147G>T
  • p.Q11H
Protein change:
Q11H
Links:
dbSNP: rs143914387
NCBI 1000 Genomes Browser:
rs143914387
Molecular consequence:
  • NM_000465.4:c.33G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282543.2:c.33G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282545.2:c.33G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282548.2:c.33G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282549.2:c.33G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104212.2:n.147G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.147G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.147G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000185949Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Dec 19, 2018)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV000682782Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Feb 11, 2015)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002529612Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Benign
(Jan 11, 2021)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP database.

Alshatwi AA, Hasan TN, Syed NA, Shafi G, Grace BL.

PLoS One. 2012;7(10):e43939. doi: 10.1371/journal.pone.0043939. Epub 2012 Oct 9.

PubMed [citation]
PMID:
23056176
PMCID:
PMC3467277

Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.

Caminsky NG, Mucaki EJ, Perri AM, Lu R, Knoll JH, Rogan PK.

Hum Mutat. 2016 Jul;37(7):640-52. doi: 10.1002/humu.22972. Epub 2016 Mar 18.

PubMed [citation]
PMID:
26898890
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV000185949.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000682782.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002529612.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024